ARTBIO

Biotech · Oslo, NO

Alpha radioligand therapies using lead-212 for cancer (lead candidate AB001)

Members see the full profile

Create a free EquityFlow account to see ARTBIO's 1 funding round, 2 investors, 12 similar companies.